Bioglaze Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-12-2024
- Paid Up Capital ₹ 1.00 M
as on 18-12-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.10 M
as on 18-12-2024
- Revenue -9.82%
(FY 2021)
- Profit 2.73%
(FY 2021)
- Ebitda -13.98%
(FY 2021)
- Net Worth 5.33%
(FY 2021)
- Total Assets -2.46%
(FY 2021)
About Bioglaze Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.10 M.
Rajeev Madan, Ajay Bhardwaj, and Sandeep Middha serve as directors at the Company.
- CIN/LLPIN
U74999HR2018PTC074338
- Company No.
074338
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Ambala, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bioglaze Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Madan  | Director | 31-May-2018 | Current |
| Ajay Bhardwaj | Director | 31-May-2018 | Current |
| Sandeep Middha | Director | 31-May-2018 | Current |
Financial Performance of Bioglaze Biotech.
Bioglaze Biotech Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 9.82% decrease. The company also saw a slight improvement in profitability, with a 2.73% increase in profit. The company's net worth moved up by a moderate rise of 5.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioglaze Biotech?
In 2021, Bioglaze Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medok Lifesciences Private LimitedActive 14 years 11 monthsRajeev Madan, Ajay Bhardwaj and 1 more are mutual person
Kolaz Biotech Private LimitedActive 10 years 9 monthsRajeev Madan, Ajay Bhardwaj and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 06 Oct 2021 | ₹0.60 M | Open |
Canara Bank Creation Date: 02 Mar 2020 | ₹1.50 M | Open |
How Many Employees Work at Bioglaze Biotech?
Unlock and access historical data on people associated with Bioglaze Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioglaze Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioglaze Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
